LIPUS Testosterone Protocols Avoid Sperm Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for boosting testosterone production, such as low-intensity pulsed ultrasound (LIPUS), have shown inconsistent results, particularly in aged males, with some studies indicating adverse effects, and there is a need for safe and effective protocols to increase endogenous testosterone levels without the side effects associated with exogenous hormone therapies.

Innovation Solution

The development of specific LIPUS dosages and treatment regimens that are safe and efficacious for increasing testosterone production in males, including aged subjects, by activating Leydig cells and utilizing novel dosing calculations to standardize energy delivery, thereby avoiding harmful effects and maintaining testosterone levels with minimal treatment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If LIPUS is applied to aged rat testes, then testosterone levels increase, but sperm production decreases substantially

Engineering Contradiction:
Improvetestosterone levelsVSAvoidsperm production reduction
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent applies periodic pulsed ultrasound treatment rather than continuous exposure. The LIPUS protocol uses intermittent pulses at specific frequencies and durations to stimulate testosterone production while allowing tissue recovery periods, thereby avoiding the detrimental effects of continuous exposure on sperm production.

Inventive Principle:
Principle #19Periodic action

Solution Approach 2:

The patent optimizes multiple parameters including ultrasound frequency, intensity, pulse duration, and treatment intervals. By carefully adjusting these parameters within specific ranges, the treatment achieves testosterone enhancement while maintaining sperm production, resolving the contradiction between these two outcomes.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If exogenous androgens are administered to treat low testosterone, then testosterone levels increase, but cardiovascular adverse events increase

Engineering Contradiction:
Improvetestosterone levelsVSAvoidcardiovascular adverse events
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent enables the body's own testicular tissue to produce testosterone through LIPUS stimulation rather than administering external hormones. This self-service approach activates endogenous testosterone synthesis pathways, avoiding the cardiovascular risks associated with exogenous androgen administration while still achieving therapeutic testosterone levels.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces the chemical/pharmacological approach (exogenous hormone administration) with a physical approach (mechanical ultrasound stimulation). By using LIPUS to mechanically stimulate testicular tissue, the treatment achieves testosterone production without the systemic effects and cardiovascular risks of hormonal medications.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Quantity of substance

If LIPUS dosage is increased to enhance testosterone production, then testosterone levels increase, but adverse side effects increase

Engineering Contradiction:
Improvetestosterone productionVSAvoidadverse side effects
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The patent establishes specific parameter ranges for LIPUS treatment including optimal frequency, intensity, and pulse duration. By maintaining parameters within these defined ranges, the treatment achieves effective testosterone enhancement while avoiding the adverse side effects that occur with excessive dosage or improper parameter settings.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent incorporates monitoring and adjustment mechanisms to optimize treatment parameters based on individual response. Through feedback from treatment outcomes, the protocol can be adjusted to maintain effective testosterone production while minimizing adverse effects, preventing overtreatment.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The described LIPUS protocols effectively and safely elevate natural testosterone levels to normal ranges, activating biological signaling pathways, and can be administered at optimized intervals to maintain testosterone production without permanent effects or adverse side effects.

Implementation Method 1

The steroid molecule testosterone is the primary sex hormone in males... the application of low-intensity pulsed ultrasound (LIPUS) to juvenile rat testes with a resulting increase in plasma testosterone

Methodology Applied
Scientific EffectLow-intensity pulsed ultrasound (LIPUS): Ultrasound

Data Source

PatentUS20230249005A1Low-Intensity Pulsed Ultrasound Enhancement of Testosterone Production
Publication Date: 2023.08.10 RGT UNIV OF CALIFORNIA
  • US20230249005A1 patent drawing
  • US20230249005A1 patent drawing
  • US20230249005A1 patent drawing

AI summary

Provided are novel dosages for the safe and efficacious application of low intensity pulsed ultrasound (LIPUS) energy to increase testosterone in a subject. These newly discovered dosage ranges specify therapeutically effective dosages that avoid harmful and inconsistent effects of LIPUS as observed in prior art attempts to implement this technology platform. Disclosed is a novel calculation of a single, biologically relevant measure of LIPUS energy dosage. By the novel integrated dosage calculations described herein, the art is provided with a tool for comparing studies and standardizing doses across a range of instruments and administration protocols. Also provided are novel medical devices and ultrasonic applicators that enable the facile administration of LIPUS to testes of subjects.